Sacituzumab govitecan

1 Drug classified under this active ingredient

Topoisomerase I Inhibitor. Sacituzumab govitecan 200 mg.
Powd. for sol. for inf.:  Dose:10 mg/kg BW admin. as IV infus. 1/w on Day 1 and Day 8 of 21-day tmt. cycles.  Should be cont. until dis. progress. or unaccept. tox.
 Monother. for adlt. pts. with unresect. or metast. triple-negat. breast cancer (mTNBC) who received two or more prior syst. ther., incl. at least one of them for adv. dis.
C/I: Hypersens.